Health

Results: 4969-4980 of 6190

Business Wire logo

New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment

MiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia’s Delivery of Nucleic Acid Therapeutics Conference

GlobeNewswire associated0

KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited Researchers Worldwide

Kyowa Kirin Successfully Completes Acquisition of Orchard Therapeutics, a Global Gene Therapy Leader for Rare Diseases

PR Newswire associated0

SHL Medical partners with SteriPack Group to set up final assembly service

Airfinity launches world’s first obesity data and analytics platform

Invitation: Sobi's Q4 and FY 2023 report

PR Newswire associated0

Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI

PR Newswire associated0

Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints

HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data

Business Wire logo

ReLive Biotechnologies Announces NDA Approval of SpheChon 10-70 spheroids/cm² by the HSA in Singapore, Marking a Milestone in ReLive’s Global Endeavors

(Graphic: Business Wire)

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development